Nicolás Anselmino

9PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 14, 2026
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial.

|Apr 13, 2026
Role of the cross-regulation between Wnt pathway activation and androgen receptor signaling in prostate cancer treatment resistance.

Nicolas Anselmino, Pablo Sanchis, Juan Bizzotto

|Aug 02, 2025
PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression.

Pablo Sanchis, Agustina Sabater, Julia Lechuga

|Nov 09, 2024
Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven Seven-Gene Stemness Signature That Predicts Progression.

Agustina Sabater, Pablo Sanchis, Rocio Seniuk

|Mar 15, 2024
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.

Nicolas Anselmino, Estefania Labanca, Peter D A Shepherd

|May 14, 2022
Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells.

Pablo Sanchis, Nicolas Anselmino, Sofia Lage-Vickers

Pageof 2

Frequent Collaborators

7 joint publications

Pablo Sanchis

6 joint publications

Juan Bizzotto

6 joint publications

Elba Vázquez

5 joint publications

Javier Cotignola